Patrick J. Balthrop - 22 Jun 2023 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Role
Director
Signature
/s/ Katie Kazem, attorney-in-fact
Issuer symbol
MXCT
Transactions as of
22 Jun 2023
Transactions value $
$0
Form type
4
Filing time
23 Jun 2023, 17:25:31 UTC
Previous filing
01 Dec 2022
Next filing
13 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MXCT Stock Option (right to buy) Award $0 +50K $0.00 50K 22 Jun 2023 Common Stock 50K $4.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this option vest on June 22, 2024, subject to the reporting person's continuous service as of such vesting date.